In the era of Bortezomib-based induction, intensification of Melphalan-based conditioning with Bortezomib does not improve survival outcomes in newly diagnosed multiple myeloma: a study from the chronic malignancies working party of the EBMT - Beksaç, Meral; Eikema, Diderik-Jan; Koster, Linda; Hulin, Cyrille; Poiré, Xavier; Hamladji, Rose-Marie; Gromek, Tomasz; Bazarbachi, Ali; Ozkurt, Zubeyde Nur; Pabst, Thomas; Ben Othman, Tarek; Finke, Jürgen; et al. (Bone marrow transplantation, 2024)
Gesehen am 01.07.2024